Want to see ANRO full AI Analyst Report?
Alto Neuroscience, Inc. (ANRO) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Alto-100 | Bipolar Disorder I Or Ii With A Major Depressive Episode | Phase II | Recruiting | ALTO-100 in Bipolar Disorder With Depression (BD-D) | Oct 15, 2024 | ― |
| Alto-101, Alto-101 Transdermal Delivery System | Schizophrenia, Cognitive Impairment | Phase II | Recruiting | Study of ALTO-101 in Patients With Schizophrenia | Jul 09, 2024 | ― |
| Alto-203 25 Μg, Alto-203 75 Μg | Major Depressive Disorder, Anhedonia | Phase II | Completed | PD, PK, and Safety of ALTO-203 in Patients With MDD | Apr 08, 2024 | ― |
| Alto-300 | Major Depressive Disorder | Phase II | Recruiting | Study of ALTO-300 in MDD | May 26, 2023 | ― |
| Alto-100 | Major Depressive Disorder | Phase II | Completed | Phase 2b Study of ALTO-100 in MDD | Dec 24, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Alto-100 | Phase II | Bipolar Disorder I Or Ii With A Major Depressive Episode | Recruiting | ALTO-100 in Bipolar Disorder With Depression (BD-D) | Oct 15, 2024 | ― |
| Alto-101, Alto-101 Transdermal Delivery System | Phase II | Schizophrenia, Cognitive Impairment | Recruiting | Study of ALTO-101 in Patients With Schizophrenia | Jul 09, 2024 | ― |
| Alto-203 25 Μg, Alto-203 75 Μg | Phase II | Major Depressive Disorder, Anhedonia | Completed | PD, PK, and Safety of ALTO-203 in Patients With MDD | Apr 08, 2024 | ― |
| Alto-300 | Phase II | Major Depressive Disorder | Recruiting | Study of ALTO-300 in MDD | May 26, 2023 | ― |
| Alto-100 | Phase II | Major Depressive Disorder | Completed | Phase 2b Study of ALTO-100 in MDD | Dec 24, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alto Neuroscience, Inc. (ANRO) have in its pipeline
Alto Neuroscience, Inc. ANRO is currently developing the following drugs: Alto-100, Alto-101, Alto-101 Transdermal Delivery System, Alto-203 25 Μg, Alto-203 75 Μg, Alto-300. These drug candidates are in various stages of clinical development as the company works toward FDA approval.